Patterns of prescription opioid use and opioid-related harms among adult patients with hematologic malignancies.
Nadia A NabulsiLisa K SharpKaren I SweissPritesh R PatelGregory Sampang CalipTodd A LeePublished in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2023)
High-risk opioid use was prevalent among patients with HM and significantly increased the risk of opioid-related harms. However, rates of opioid-related harms were low. These findings highlight the importance of continually monitoring pain and opioid use throughout HM survivorship to provide safe, effective HM pain management.